Ultra-fractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy

Background

Source: Radiotherapy and Oncology - February 24, 2021 Category: Radiology Authors: Yat Man Tsang, Hannah Tharmalingam, Katherine Belessiotis-Richards, Shreya Armstrong, Peter Ostler, Robert Hughes, Roberto Alonzi, Peter J Hoskin Tags: Guidelines Source Type: research